Veru, Inc. (VERU) Reports Q3, Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. USO
8. IBM
9. HOOD
10. DFTX

Go back to Veru, Inc. (VERU) Reports Q3, Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories

Veru, Inc. (VERU) Halted on Volatility

August 11, 2022 9:39 AM EDT

Veru, Inc. (NASDAQ: VERU) Halted on Volatility

... More